Novel Non-Immunologic Agents for Relapsed and Refractory Multiple Myeloma: A Review Article

Novel Non-Immunologic Agents for Relapsed and Refractory Multiple Myeloma: A Review Article

Novel treatments are needed to address the lack of options for patients with relapsed or refractory multiple myeloma. Even though immunotherapy-based treatments have revolutionized the field in recent years, offering new opportunities for patients, there is still no curative therapy. Thus, non-immun...

Full description

Bibliographic Details
Main Authors: Arthur Bobin, Cécile Gruchet, Stéphanie Guidez, Hélène Gardeney, Laly Nsiala Makunza, Mathilde Vonfeld, Anthony Lévy, Laura Cailly, Florence Sabirou, Thomas Systchenko, Niels Moya, Xavier Leleu
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Cancers
Subjects:
multiple myeloma
non-immunologic agents
relapsed or refractory
IMiDs
proteasome inhibitors
XPO1 inhibitors
Online Access:https://www.mdpi.com/2072-6694/13/20/5210

Internet

https://www.mdpi.com/2072-6694/13/20/5210

Similar Items